Sri Lanka COVID vaccination: All you need to know about COVISHIELD vaccine

Friday, 29 January 2021 - 11:15

Sri+Lanka+COVID+vaccination%3A+All+you+need+to+know+about+COVISHIELD+vaccine
The Health Promotion Bureau has stated that common side effects of the Oxford- AstraZeneca COVISHIELD vaccine are Tenderness, pain, warmth, redness, itching, swelling or bruising where the injection is given, feeling tired (fatigue) and unwell, chills or feeling feverish, headache, nausea, joint pain or muscle aches and mild flu-like symptoms.

They noted that the uncommon side effects of the virus are feeling dizzy, decreased appetite, abdominal pain, enlarged lymph nodes, excessive sweating, itchiness and rash.

The HPB further stated that while rare severe adverse reactions are not explained to date (from trials) but rare severe adverse reactions can occur for any pharmaceutical product.

The vaccines will not be given to persons who are hypersensitive to known components in the vaccine (List of excipients: L-Histidine, L-Histidine hydrochloride monohydrate, Magnesium chloride hexahydrate, Polysorbate 80, Ethanol, Sucrose, Sodium chloride, Disodium edetate dihydrate (EDTA), Water for injection), and to those who have showcased immediate or delayed severe allergic or anaphylactic reaction after a previous dose of the COVISHIELD vaccine.

The vaccine will also be withheld from persons who have showcased immediate or delayed onset anaphylactic or severe allergic reaction to vaccines or injectable therapies, pharmaceutical products, food items etc.

Since the clinical trials are yet to be conducted, pregnant and lactating mothers, as well as children below the age of 18, will also not receive the COVISHIELD vaccine.

The HPB noted that special caution must be followed when vaccinating persons with a history of any bleeding or coagulation disorders (e.g. clotting factor deficiency, coagulopathy, platelet disorders).

The authorities noted that the vaccination will be postponed for four to eight weeks in the situation a person is showing any signs of COVID-19 infection or suffering from any other acute illness who are not fit for the vaccination and already diagnosed COVID-19 patient who has received anti-COVID monoclonal antibodies or convalescent plasma as a treatment option.

The full statement by the Health Promotion Bureau can be read here. 

You frequently asked questions are answered here. 

Share
Share to Facebook Share to Facebook Share to Facebook Share to Facebook Share to Facebook Share to Facebook

Follow US

facebook 32ins twitter 32ins


Most Viewed Stories